Geron Corporation (GERN): Price and Financial Metrics
GERN Price/Volume Stats
| Current price | $1.60 | 52-week high | $5.34 |
| Prev. close | $1.56 | 52-week low | $1.17 |
| Day low | $1.56 | Volume | 8,806,310 |
| Day high | $1.63 | Avg. volume | 13,841,665 |
| 50-day MA | $1.40 | Dividend yield | N/A |
| 200-day MA | $2.99 | Market Cap | 1.02B |
GERN Stock Price Chart Interactive Chart >
Geron Corporation (GERN) Company Bio
Geron Corporation focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California.
GERN Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GERN Price Returns
| 1-mo | 22.14% |
| 3-mo | -7.51% |
| 6-mo | -59.29% |
| 1-year | -58.87% |
| 3-year | 16.79% |
| 5-year | 3.90% |
| YTD | -54.80% |
| 2024 | 67.77% |
| 2023 | -12.81% |
| 2022 | 98.36% |
| 2021 | -23.27% |
| 2020 | 16.91% |